Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis

MARIA MERCEDES GIL CAMPOS2026-01-292026-01-29201810.1007/s10545-018-0175-22-s2.0-85046469544https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/29140GeneticsGenetics (clinical)Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosisresearch article